NC
KYNB

Nexthera Capital’s Kyntra Bio KYNB Stock Holding History

Nexthera Capital’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,017
Closed -$3.06M – 32
2018
Q3 		$3.06M Sell
2,017
-3,406
-63% -$5.25M 0.59% 33
2018
Q2 		$8.49M Sell
5,423
-613
-10% -$799K 1.31% 23
2018
Q1 		$6.97M Sell
6,036
-1,998
-25% -$2.63M 1.15% 26
2017
Q4 		$9.52M Sell
8,034
-659
-8% -$826K 1.76% 17
2017
Q3 		$11.7M Buy
+8,693
New +$9.16M 3.01% 7
2017
Q1 		– Sell
-4,640
Closed -$2.48M – 40
2016
Q4 		$2.48M Sell
4,640
-467
-9% -$233K 1.45% 19
2016
Q3 		$2.64M Sell
5,107
-1,053
-17% -$496K 1.62% 18
2016
Q2 		$2.53M Buy
+6,160
New +$2.82M 2.19% 12

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nexthera Capital's KYNB Position: Q4 2018 in Review

Nexthera Capital sold out of Kyntra Bio (KYNB) in Q4 2018, closing a stake of 2,017 shares — an estimated $3.06M sold.

Nexthera Capital first reported a position in KYNB in Q2 2016 and held it in 8 quarters. The position peaked at $11.7M in Q3 2017. 201 funds tracked by Wall St. Rank hold KYNB as of Q4 2018.

  • Nexthera Capital reported no remaining Kyntra Bio position as of Q4 2018 after selling out during the quarter.
  • Nexthera Capital sold 2,017 Kyntra Bio shares in Q4 2018, an estimated $3.06M.
  • Nexthera Capital first reported a position in Kyntra Bio in Q2 2016 and held it in 8 quarters.
  • Nexthera Capital's Kyntra Bio position peaked at $11.7M in Q3 2017.
  • 201 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.